Slingshot members are tracking this event:
GlycoMimetics' GMI-1271 Receives FDA Fast Track Designation for Treatment of Acute Myeloid Leukemia
Slingshot Insights Explained
Jun 13, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Acute Myeloid Leukemia, Fast Track Designation, Fda, Gmi-1271